ANL (Adlai Nortye) Shares Outstanding (EOP): 40.00 Mil (As of Dec. 2025)


What is Adlai Nortye Shares Outstanding (EOP)?

Adlai Nortye ANL +3.33% Shares Outstanding (EOP) is 40.00 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Adlai Nortye's shares outstanding for the quarter that ended in Dec. 2025 was 40.00 Mil.

Adlai Nortye's quarterly shares outstanding increased from Jun. 2025 (36.90 Mil) to Dec. 2025 (40.00 Mil). It means Adlai Nortye issued new shares from Jun. 2025 to Dec. 2025 .

Adlai Nortye's annual shares outstanding increased from Dec. 2024 (36.90 Mil) to Dec. 2025 (40.00 Mil). It means Adlai Nortye issued new shares from Dec. 2024 to Dec. 2025 .


Adlai Nortye  (NAS:ANL) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Adlai Nortye Shares Outstanding (EOP) Related Terms


Adlai Nortye Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Adlai Nortye's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adlai Nortye Shares Outstanding (EOP) Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
36.90 36.90 36.90 36.90 40.00

Adlai Nortye Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only 36.90 36.90 36.90 36.90 40.00

ANL vs OMER, PRME, DNA: Shares Outstanding (EOP) Comparison

For the Biotechnology subindustry, Adlai Nortye's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adlai Nortye Shares Outstanding (EOP) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's Shares Outstanding (EOP) falls into.



Adlai Nortye Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 40.00 Mil mean?
Adlai Nortye (ANL) has a Shares Outstanding (EOP) of 40.00 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Adlai Nortye and its competitors.
Is Adlai Nortye's Shares Outstanding (EOP) too high?
Adlai Nortye's current Shares Outstanding (EOP) is 40.00 Mil.
How does Adlai Nortye's Shares Outstanding (EOP) compare to OMER and PRME?
Adlai Nortye's Shares Outstanding (EOP) of 40.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Biotechnology company?
A good Shares Outstanding (EOP) depends on the Biotechnology industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Adlai Nortye and its competitors. Adlai Nortye's current Shares Outstanding (EOP) is 40.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adlai Nortye stock overvalued right now?
Adlai Nortye (ANL) has a current Shares Outstanding (EOP) of 40.00 Mil. The current Shares Outstanding (EOP) is 40.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Adlai Nortye (ANL), the current Shares Outstanding (EOP) is 40.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adlai Nortye Business Description

Other Exchanges N2U0:Germany
Address 685 US Highway 1, New Jersey Biotechnology Development Center, 2nd Floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.